Galectin Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Galectin Therapeutics Inc. has filed definitive additional proxy materials with the SEC.
NASDAQ
Galectin Therapeutics Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 3, 2025, to vote on director elections, executive compensation, auditor ratification, and other business.
NASDAQ
Galectin Therapeutics Inc. has filed its definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
Galectin Therapeutics will hold its 2024 annual meeting of stockholders virtually on January 23, 2025, to elect directors and ratify the appointment of its independent auditor.